Print Page  |  Close Window

Press Release

<< Back
CVS/Caremark Corporation Ranks Among Best in J.D. Power and Associates 2007 Retail Pharmacy Satisfaction Study(SM)

Caremark Rx and PharmaCare Lead Mail Order Segment CVS/pharmacy Ranks Highly among National Chain Pharmacies

WOONSOCKET, R.I., April 17 /PRNewswire-FirstCall/ -- CVS/Caremark Corporation (NYSE: CVS) announced that its mail order and retail pharmacy businesses rank highly in the J.D. Power and Associates 2007 Retail Pharmacy Satisfaction Study(SM) released today. The study was conducted in the Fall of 2006, prior to the closing of the CVS/Caremark merger. Therefore, results for Caremark Rx, Inc., PharmaCare, and CVS/pharmacy are reported separately.

"We're thrilled with the strong showing by CVS/Caremark in the J.D. Power and Associates study," said Tom Ryan, President and CEO of CVS/Caremark Corporation. "The study shows that consumers are making careful evaluations of the services that they receive when they fill prescriptions based on important criteria, such as convenience, availability of medication and interaction with the pharmacist, all areas in which CVS/Caremark scored well."

Caremark Rx ranked highest overall in the mail order segment and ranked highest in two of the five major performance factors that were used in the study to indicate customer satisfaction. Notably, Caremark was highest in a tie in availability of medication and information and tied for highest in convenience. In addition, Caremark exceeded the mail order segment average for layout and design and non-pharmacist staff.

PharmaCare, which ranked second overall in the mail order segment, rated highest on competitiveness of pricing and non-pharmacist staff. PharmaCare exceeded the segment average on convenience.

CVS/pharmacy ranked second among national retail chain pharmacies overall, after Medicine Shoppe, as measured by the six major performance factors used to measure chain pharmacies, including convenience, non-pharmacist staff, medication availability and information, store layout and design, competitiveness of pricing, and pharmacist. CVS/pharmacy ranked second among national chain pharmacies (after Medicine Shoppe) in the pharmacist performance factor, medication availability and information, and non- pharmacist staff.

"This study shows that CVS/Caremark is well-positioned among consumers not only because of its strong study performance but also because the specific areas that are recommended by J.D. Power and Associates as ways to improve customer satisfaction, such as making the pharmacist connection, engaging the customer, and providing in-store clinics, are all areas on which CVS/Caremark is focusing," added Ryan. "CVS/Caremark as a newly combined company will improve the delivery of pharmacy services by expanding access, convenience and choice for consumers."

About CVS/Caremark

CVS/Caremark is the nation's premier integrated pharmacy services provider, combining one of the nation's leading pharmaceutical services companies with the country's largest pharmacy chain. The company fills or manages more than one billion prescriptions per year, more than any other pharmacy services provider. CVS/Caremark drives value for pharmacy services customers by effectively managing pharmaceutical costs and improving healthcare outcomes through its 6,200 CVS/pharmacy stores; its pharmacy benefit management, mail order and specialty pharmacy division, Caremark Pharmacy Services; its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, CVS.com. General information about CVS/Caremark is available through the Investor Relations portion of the Company's website, at http://investor.cvs.com, as well as through the pressroom portion of the Company's website, at http://www.cvs.com/pressroom.


     Investor Contact:             Media Contact:
     Nancy Christal                Eileen Howard Dunn
     CVS/Caremark                  CVS/Caremark
     Investor Relations            Corporate Communications
     (914) 722-4704                (401) 770-4561